Serum Levels of 25-Hydroxy Vitamin D in Patients with Hepatitis C Compared with Control Group

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Infectious Diseases, School of Medicine AND Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2 Student of Medicine, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Some studies suggest that besides the known effects of vitamin D on calcium hemostasis and bone safety, it might also play a non-classic role in our body such as in chronic hepatic disorders. So, considering the high prevalence of vitamin D deficiency and HCV in our society, the aim of this study was to evaluate serum levels of vitamin D in HCV patients compared to a control group.Methods: In this case-control study, 60 HCV patients and 60 healthy pupils were selected and serum level of vitamin D was measured and compared between the two groups.Findings: The mean serum level of Vitamin D in the case and control group was 26.23 ± 18.53 and 29.6 ± 13.61, respectively and no statistical difference was reported between the two groups (P = 0.260). Vitamin D insufficiency was found in 3 patients (5.0%) in the case group and none of the control group. Vitamin D deficiency was found in 43(71.7%) of the case group but only 6 (10.0%) of the control group and this difference between the two group was statistically significant (P = 0.033).Conclusion: According to the results of this study, vitamin D deficiency in HCV patients was higher than the normal population and high prevalence of vitamin D deficiency can affect other organs and decrease the quality of HCV treatment. Thus, measuring the serum levels of vitamin D in HCV patients and prescribing vitamin D supplements are recommended. 

Keywords

References

  1. Beltran M, Navas MC, de la Hoz F, Mercedes MM, Jaramillo S, Estrada C, et al. Hepatitis C virus seroprevalence in multi-transfused patients in Colombia. J Clin Virol 2005; 34(Suppl 2): S33-S38.
  2. Zahedi MJ, Zand V, Tavakoli M, Hajarizadeh B, Alavian SM. The prevalence of hepatitis B and C among thalassemia major patients in Kerman, Iran, and the role of transfusion in infection acquisition. Govaresh 2003; 8(44): 72-8. [In Persian].
  3. Hosseinnezhad A, Javadi E, Maghbooli Z, Madani FS, Ardeshir Larijani MB. Normal range of vitamin D: relationship between serum PTH and bone mineral density. Payesh Health Monit 2004; 3(1): 19-25. [In Persian].
  4. Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, et al. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol 2011; 54(5): 887-93.
  5. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun 2008; 76(9): 3837-43.
  6. Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010; 55(9): 2624-8.
  7. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79(3): 362-71.
  8. Lim LY, Chalasani N. Vitamin D deficiency in patients with chronic liver disease and cirrhosis. Curr Gastroenterol Rep 2012; 14(1): 67-73.
  9. Bouillon R, Auwerx J, Dekeyser L, Fevery J, Lissens W, de Moor P. Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 1984; 59(1): 86-9.
  10. Petta S, Camma C, Scazzone C, Tripodo C, di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51(4): 1158-67.
  11. Fisher AA, Davis MW. Calcium-PTH-vitamin D axis in older patients with hip fracture. Osteoporos Int 2007; 18(5): 693-5.
  12. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007; 5(4): 513-20.
  13. Chojkier M. Effects of vitamin D on inflammation in liver disease [Online]. [cited 2012 Dec]; Available from: URL:
  14. https://clinicaltrials.gov/ct2/show/NCT01754961
  15. Bauman WA, Zhong YG, Schwartz E. Vitamin D deficiency in veterans with chronic spinal cord injury. Metabolism 1995; 44(12): 1612-6.
Journal of Isfahan Medical School
Volume 34, Issue 370 - Serial Number 370
January and February 2016
Pages 49-55

Files

History

  • Receive Date: 26 October 2015
  • Revise Date: 26 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics